Article, Early Access, 2024

Pharmacokinetic and pharmacodynamic evaluation of nitrofurantoin against Escherichia coli in a murine urinary tract infection model

APMIS, ISSN 0903-4641, 10.1111/apm.13409

Contributors

Maaland, Marit Gaastra [1] [2] Jakobsen, Lotte [3] [4] Guardabassi, Luca [2] Frimodt-Moller, Niels (Corresponding author) [2] [5]

Affiliations

  1. [1] Norwegian Univ Life Sci, Dept Prod Anim Clin Sci, Sandnes, Norway
  2. [NORA names: Norway; Europe, Non-EU; Nordic; OECD];
  3. [2] Copenhagen Univ Hosp, Dept Clin Microbiol, Rigshosp, Blegdamsvej 9, DK-2100 Copenhagen O, Denmark
  4. [NORA names: KU University of Copenhagen; University; Denmark; Europe, EU; Nordic; OECD];
  5. [3] Device & Delivery Solut, Hillerod, Denmark
  6. [NORA names: Miscellaneous; Denmark; Europe, EU; Nordic; OECD];
  7. [4] Statens Serum Inst, Microbiol & Infect Control, Copenhagen, Denmark
  8. [NORA names: SSI Statens Serum Institut; Governmental Institutions; Denmark; Europe, EU; Nordic; OECD];
  9. [5] Copenhagen Univ Hosp, Dept Clin Microbiol, Rigshosp, Blegdamsvej 9, DK-2100 Copenhagen O, Denmark
  10. [NORA names: Capital Region of Denmark; Hospital; Denmark; Europe, EU; Nordic; OECD]

Abstract

Abstract not displayed. As this article is not marked as Open Access, it is unclear if we are allowed to show the abstract. Please use the link in the sidebar to view the data provider version of the article including abstract.

Keywords

Escherichia coli, Nitrofurantoin, mouse infection model, pharmacokinetic/pharmacodynamic, urinary tract infection

Data Provider: Clarivate